Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
This Quarter Return
+9.04%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$3.92B
AUM Growth
+$3.92B
(+8.9%)
Cap. Flow
+$65.5M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
186
New
18
Increased
68
Reduced
45
Closed
17
Top Buys
| 1 |
UnitedHealth
UNH
|
$27.5M |
| 2 |
Protolabs
PRLB
|
$27.3M |
| 3 |
Watsco
WSO
|
$27M |
| 4 |
Albemarle
ALB
|
$25.7M |
| 5 |
Alibaba
BABA
|
$25.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$28.1M |
| 2 |
TWX
Time Warner Inc
TWX
|
$23.8M |
| 3 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
$23.4M |
| 4 |
NetEase
NTES
|
$22.5M |
| 5 |
IAC Inc
IAC
|
$18.6M |
Sector Composition
| 1 | Consumer Discretionary | 18.77% |
| 2 | Healthcare | 14.34% |
| 3 | Financials | 14.32% |
| 4 | Technology | 14.29% |
| 5 | Communication Services | 13.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Acuity Brands
AYI
$10B
| $8.93M | 0.23% | 43,916 -3,801 | -8% | -$773K |
|
|
MOMO
102
Hello Group
MOMO
$1.33B
| $8.87M | 0.23% | 240,000 +165,000 | +220% | +$6.1M |
|
103
Estee Lauder
EL
$33B
| $8.75M | 0.22% | 91,200 +1,200 | +1% | +$115K |
|
104
Exelixis
EXEL
$10.1B
| $8.6M | 0.22% | 349,000 | – | – |
|
105
Cavco Industries
CVCO
$4.2B
| $8.43M | 0.21% | +65,000 | New | +$8.43M |
|
106
Affiliated Managers Group
AMG
$6.39B
| $8.29M | 0.21% | 50,000 -107,700 | -68% | -$17.9M |
|
107
JD.com
JD
$44.1B
| $8.24M | 0.21% | +210,000 | New | +$8.24M |
|
108
FibroGen
FGEN
$47.8M
| $7.72M | 0.2% | 239,000 | – | – |
|
|
PFPT
109
DELISTED
Proofpoint, Inc.
PFPT
| $7.38M | 0.19% | 85,000 +2,000 | +2% | +$174K |
|
110
TAL Education Group
TAL
$6.46B
| $7.34M | 0.19% | 60,000 | – | – |
|
111
Aptiv
APTV
$17.3B
| $7.01M | 0.18% | 80,000 | – | – |
|
|
AERI
112
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.83M | 0.17% | 130,000 +57,000 | +78% | +$3M |
|
113
Neurocrine Biosciences
NBIX
$13.8B
| $6.81M | 0.17% | 148,000 +28,000 | +23% | +$1.29M |
|
114
IMAX
IMAX
$1.54B
| $6.6M | 0.17% | 300,000 +170,000 | +131% | +$3.74M |
|
115
Gilead Sciences
GILD
$140B
| $6.36M | 0.16% | 89,870 | – | – |
|
116
Baxter International
BAX
$12.7B
| $6.3M | 0.16% | 104,000 +11,000 | +12% | +$666K |
|
|
BETR
117
DELISTED
Amplify Snack Brands, Inc.
BETR
| $6.27M | 0.16% | 650,000 +75,000 | +13% | +$723K |
|
118
Evolent Health
EVH
$1.12B
| $6.21M | 0.16% | 245,000 +165,000 | +206% | +$4.18M |
|
119
Pfizer
PFE
$141B
| $6.1M | 0.16% | 181,630 -20,000 | -10% | -$672K |
|
120
Merck
MRK
$210B
| $6.09M | 0.16% | 95,000 -14,000 | -13% | -$897K |
|
121
Fomento Económico Mexicano
FMX
$30.1B
| $6.08M | 0.16% | 61,820 | – | – |
|
122
Exact Sciences
EXAS
$8.98B
| $6.01M | 0.15% | +170,000 | New | +$6.01M |
|
123
Expedia Group
EXPE
$26.6B
| $5.96M | 0.15% | 40,000 -10,000 | -20% | -$1.49M |
|
124
Microchip Technology
MCHP
$35.1B
| $5.9M | 0.15% | +76,400 | New | +$5.9M |
|
125
Glaukos
GKOS
$5.5B
| $5.85M | 0.15% | 141,000 -4,000 | -3% | -$166K |
|